Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina Date Wednesday, March 09, 2022 - 5:00 PM Description
Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use Date Wednesday, March 09, 2022 - 7:00 AM Description
Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2 Date Wednesday, March 09, 2022 - 7:00 AM Description
Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults Date Wednesday, March 02, 2022 - 5:00 PM Description
Oral Health for All — Realizing the Promise of Science Date Wednesday, March 02, 2022 - 5:00 PM Description
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants Date Wednesday, March 02, 2022 - 5:00 PM Description